The Duke Clinical and Translational Science Institute (CTSI) is collaborating with Duke Emergency Medicine on a public health surveillance project dubbed Preventing Emerging Infections Through Vaccine Effectiveness Testing, or PREVENT II. Anyone who works at a Duke Health location and has recently been tested for COVID-19, whether positive or negative for infection, may be eligible to participate.